Avipsa Bose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Avipsa Bose has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Sandhya Srikant Visweswariah
Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, India
5 shared publications - Arka Banerjee
Department of Microbiology and Immunology Weill Cornell Medical College New York New York USA
2 shared publications Harini Ramani
2 shared publicationsPriyanka Biswas
Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, India
2 shared publicationsRuchi Chaturvedi
Department of Microbiology and Cell Biology, Centre for Infectious Disease Research, Indian Institute of Science, Bengaluru, India
2 shared publications- Sanghita Banerjee
Indian Institute of Science
2 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Elsevier in Insights in Biochemistry and Molecular Biology
- Vol. 1 (3)
Guanylyl cyclase C hyperactivation drives pathological cardiac remodeling and dysfunction in mice
- 27 October 2026
- Published by Elsevier in Insights in Biochemistry and Molecular Biology
- Vol. 1 (3)
Open AccessGuanylyl cyclase C hyperactivation drives pathological cardiac remodeling and dysfunction in mice
- 1 August 2026
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 331 (2) , G125-G139
Therapeutic zinc targets dysregulated GC-C signaling and restores ileal defects in a preclinical model of familial diarrheal disease
Activating mutations in GUCY2C, which encodes the receptor guanylyl cyclase C (GC-C), cause early-onset diarrheal disease and gastrointestinal inflammation. Knock-in mice carrying a familial diarrheal syndrome mutation exhibited impaired gut barrier function. Mutant organoids showed defective secretory lineage specification associated with reduced Wnt3 expression. Zinc administration, which lowers epithelial cGMP levels by inhibiting GC-C, reversed most pathological changes in both mice and organoids.
- 1 August 2026
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 331 (2) , G125-G139
Therapeutic zinc targets dysregulated GC-C signaling and restores ileal defects in a preclinical model of familial diarrheal disease
Activating mutations in GUCY2C, which encodes the receptor guanylyl cyclase C (GC-C), cause early-onset diarrheal disease and gastrointestinal inflammation. Knock-in mice carrying a familial diarrheal syndrome mutation exhibited impaired gut barrier function. Mutant organoids showed defective secretory lineage specification associated with reduced Wnt3 expression. Zinc administration, which lowers epithelial cGMP levels by inhibiting GC-C, reversed most pathological changes in both mice and organoids.
- Open Access
- 13 August 2025
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 482 (16) , 1079-1103
Gut reactions and gut instincts: regulation of intestinal homeostasis by receptor guanylyl cyclase C (GC-C)
The important role that the gut plays in directing and modulating the well-being of the entire organism cannot be underestimated. We are beginning to dissect molecular players that are intrinsic to the functioning of the epithelial cells of the gut, which, in turn, control the responses of various tissues. In this review, we provide an overview of the role of a receptor guanylyl cyclase in regulating fluid–ion homeostasis, cell proliferation and the microbiome in the gut. Further elucidation of molecular details, aided by the development of novel mouse models and organoid cultures, should increase our understanding of the role of this receptor and cyclic guanosine 3′,5′-monophosphate in congenital secretory diarrhoea and inflammatory bowel disease.
- 13 August 2025
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 482 (16) , 1079-1103
Open AccessGut reactions and gut instincts: regulation of intestinal homeostasis by receptor guanylyl cyclase C (GC-C)
The important role that the gut plays in directing and modulating the well-being of the entire organism cannot be underestimated. We are beginning to dissect molecular players that are intrinsic to the functioning of the epithelial cells of the gut, which, in turn, control the responses of various tissues. In this review, we provide an overview of the role of a receptor guanylyl cyclase in regulating fluid–ion homeostasis, cell proliferation and the microbiome in the gut. Further elucidation of molecular details, aided by the development of novel mouse models and organoid cultures, should increase our understanding of the role of this receptor and cyclic guanosine 3′,5′-monophosphate in congenital secretory diarrhoea and inflammatory bowel disease.
- Open Access
- 16 April 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (5) , 107287
Cyclic AMP binding to a universal stress protein in Mycobacterium tuberculosis is essential for viability
- 16 April 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (5) , 107287
Open AccessCyclic AMP binding to a universal stress protein in Mycobacterium tuberculosis is essential for viability
- Open Access
A universal stress protein is essential for the survival of Mycobacterium tuberculosis
Mycobacterium tuberculosis employs several signaling pathways to regulate its cellular physiology and survival within the host. Mycobacterial genomes encode multiple adenylyl cyclases and cAMP effector proteins, underscoring the diverse ways in which these bacteria utilize cAMP. We have earlier identified universal stress proteins (USP), Rv1636 and MSMEG_3811 in M. tuberculosis and M. smegmatis respectively, as abundantly expressed, novel cAMP-binding proteins. In this study, we show that these USPs may function to regulate cAMP signaling by direct sequestration of the second messenger. In slow-growing mycobacteria, concentrations of Rv1636 were equivalent to the amounts of cAMP present in the cell, and overexpression of Rv1636 in M. smegmatis increased levels of ‘bound’ cAMP. Rv1636 is secreted via the SecA2 secretion system in M. tuberculosis but is not directly responsible for the efflux of cAMP from the cell. While msmeg_3811 could be readily deleted from the genome of M. smegmatis , we find that the rv1636 gene is essential for growth of M. tuberculosis , and this functionality depends on the cAMP-binding ability of Rv1636. This is the first evidence of a ‘sink’ for any second messenger in bacterial signaling that would allow mycobacterial cells to regulate the available intracellular ‘free’ pool of cAMP.
Open AccessA universal stress protein is essential for the survival of Mycobacterium tuberculosis
Mycobacterium tuberculosis employs several signaling pathways to regulate its cellular physiology and survival within the host. Mycobacterial genomes encode multiple adenylyl cyclases and cAMP effector proteins, underscoring the diverse ways in which these bacteria utilize cAMP. We have earlier identified universal stress proteins (USP), Rv1636 and MSMEG_3811 in M. tuberculosis and M. smegmatis respectively, as abundantly expressed, novel cAMP-binding proteins. In this study, we show that these USPs may function to regulate cAMP signaling by direct sequestration of the second messenger. In slow-growing mycobacteria, concentrations of Rv1636 were equivalent to the amounts of cAMP present in the cell, and overexpression of Rv1636 in M. smegmatis increased levels of ‘bound’ cAMP. Rv1636 is secreted via the SecA2 secretion system in M. tuberculosis but is not directly responsible for the efflux of cAMP from the cell. While msmeg_3811 could be readily deleted from the genome of M. smegmatis , we find that the rv1636 gene is essential for growth of M. tuberculosis , and this functionality depends on the cAMP-binding ability of Rv1636. This is the first evidence of a ‘sink’ for any second messenger in bacterial signaling that would allow mycobacterial cells to regulate the available intracellular ‘free’ pool of cAMP.
- Open Access
- 21 September 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (11)
Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C
Activating mutations in receptor guanylyl cyclase C (GC-C), the target of gastrointestinal peptide hormones guanylin and uroguanylin, and bacterial heat-stable enterotoxins cause early-onset diarrhea and chronic inflammatory bowel disease (IBD). GC-C regulates ion and fluid secretion in the gut via cGMP production and activation of cGMP-dependent protein kinase II. We characterize a novel mouse model harboring an activating mutation in Gucy2c equivalent to that seen in an affected Norwegian family. Mutant mice demonstrated elevated intestinal cGMP levels and enhanced fecal water and sodium content. Basal and linaclotide-mediated small intestinal transit was higher in mutant mice, and they were more susceptible to DSS-induced colitis. Fecal microbiome and gene expression analyses of colonic tissue revealed dysbiosis, up-regulation of IFN-stimulated genes, and misregulation of genes associated with human IBD and animal models of colitis. This novel mouse model thus provides molecular insights into the multiple roles of intestinal epithelial cell cGMP, which culminate in dysbiosis and the induction of inflammation in the gut.
- 21 September 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (11)
Open AccessGut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C
Activating mutations in receptor guanylyl cyclase C (GC-C), the target of gastrointestinal peptide hormones guanylin and uroguanylin, and bacterial heat-stable enterotoxins cause early-onset diarrhea and chronic inflammatory bowel disease (IBD). GC-C regulates ion and fluid secretion in the gut via cGMP production and activation of cGMP-dependent protein kinase II. We characterize a novel mouse model harboring an activating mutation in Gucy2c equivalent to that seen in an affected Norwegian family. Mutant mice demonstrated elevated intestinal cGMP levels and enhanced fecal water and sodium content. Basal and linaclotide-mediated small intestinal transit was higher in mutant mice, and they were more susceptible to DSS-induced colitis. Fecal microbiome and gene expression analyses of colonic tissue revealed dysbiosis, up-regulation of IFN-stimulated genes, and misregulation of genes associated with human IBD and animal models of colitis. This novel mouse model thus provides molecular insights into the multiple roles of intestinal epithelial cell cGMP, which culminate in dysbiosis and the induction of inflammation in the gut.